Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oncocyte Corp (NQ: OCX ) 2.880 -0.090 (-3.03%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10,293 Open 2.930 Bid (Size) 2.850 (1) Ask (Size) 3.000 (10) Prev. Close 2.970 Today's Range 2.840 - 2.987 52wk Range 2.080 - 4.340 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024 August 08, 2024 OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via AB Newswire Performance YTD -12.73% -12.73% 1 Month -4.95% -4.95% 3 Month -2.37% -2.37% 6 Month -3.36% -3.36% 1 Year -10.00% -10.00% More News Read More OncoCyte's Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via News Direct OncoCyte's Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via TheNewswire.com 4 Analysts Assess OncoCyte: What You Need To Know May 16, 2024 Via Benzinga OncoCyte's Earnings: A Preview November 08, 2023 Via Benzinga Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier September 18, 2023 Via ACCESSWIRE Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference September 06, 2023 Via ACCESSWIRE OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 Via InvestorPlace 3 Penny Stocks That Insiders Are Buying May 07, 2024 Via MarketBeat 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 23, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 15, 2024 Via InvestorPlace Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage August 28, 2023 Via ACCESSWIRE Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Via Benzinga Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket April 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session April 12, 2024 Via Benzinga OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023 April 12, 2024 Via InvestorPlace Top 3 Health Care Stocks That May Collapse In Q2 April 12, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 12, 2024 Via InvestorPlace Earnings Scheduled For April 12, 2024 April 12, 2024 Via Benzinga Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket April 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session November 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 09, 2023 Via Benzinga Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 09, 2023 Via Benzinga Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session October 25, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
